"This is the best use of my time to remain current with what is going on in the industry."
The current regulatory expectation is the investigators review and sign-off the data entered into eCRFs and other data collection tools at critical timings (including prior to interim analysis and the final analysis) in a timely manner. eClinical Forum issued a best practices document titled “Investigator’s signature on electronic Case Report Forms (eCRFs) in 2017. This team will review and align this existing document with most recent regulatory expectations on signatures collection on eCRF and eCOA data. A draft is anticipated in October 2021 and the release to the members by end of December 2021.
Americas Autumn Workshop, October 13-15, 2026, Bloomington IL, USA, hosted by GenInvo
APAC/Hybrid Autumn Workshop, October 22-23, 2026, Shanghai, China, hosted by Clario
Europe/Hybrid Autumn Workshop, October 27-29, 2026, Zurich, Switzerland, hosted by BSI Software
eCF Webinar November: FDA warning letters for audit trail analytics
FDA warning letters tell us what went wrong, but what could your audit trail analytics program have caught earlier? Join our upcoming webinar for a practical, in-depth look at an FDA warning letter and learn how to identify missed signals, uncover blind spots, and strengthen your audit trail review program.